GASTROENTEROL REP 润色咨询

Gastroenterology Report

出版年份：暂无数据 年文章数：401 投稿命中率： 开通期刊会员，数据随心看

出版周期：Quarterly 自引率：3.1% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=589747, encodeId=1d0e589e47f8, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：投了一篇儿科普外科罕见病，一审1个月15天，意见是大修，但审稿意见基本没有需要改的，2天修回，碰到疫情，二审1个月后直接接受！历时3个月15天！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/07/ef2e683cb55b8fad1c6a2183144a4b1c.jpg, createdBy=6fee2203247, createdName=EthanYan, createdTime=Sun Apr 26 00:00:00 CST 2020, time=2020-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161543, encodeId=1f32216154340, content=偏重的研究方向：EUS<br>经验分享：目前Awaiting Reviewer Selection 状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb1a5029527, createdName=c040149, createdTime=Sun Oct 08 14:28:29 CST 2023, time=2023-10-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2149854, encodeId=e57721498548c, content=awaiting recommendation一般持续多久<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e4a12389361, createdName=婆婆丁, createdTime=Tue Jul 25 23:21:37 CST 2023, time=2023-07-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=589587, encodeId=244058958e35, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：其官网显示刊稿范围包括消化道（食管、胃、小肠、结直肠、肛门）、消化腺（肝、胆、胰、脾）以及肠内营养等相关学科的研究报道，旨在刊载胃肠病学领域的科研新成果、临床新技术、诊治新理念，文章类型包括评论、共识、综述、短篇报道、论著等。双月刊，JCR胃肠病学分区3区。 <br> 投稿系统简介便利，投稿一个月左右收到初审反馈，但感觉其网站作者指引不是特别明晰，因此后期修稿稍耗时。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c84c5323115, createdName=MedMN, createdTime=Fri Apr 24 10:12:00 CST 2020, time=2020-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920186, encodeId=d7389201869f, content=投了一篇临床研究。接受22天了，还没有给proof和要求交费，大家之前是多久收到的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJezw9rLVo7scpm4bIb34WhXb0deaXB8picW5eMAazAJHqyt2iaj4Zw6Uecu7jrAcuWiax5TTGr2reoA/132, createdBy=02e72292772, createdName=Godmin, createdTime=Wed Jan 27 07:15:07 CST 2021, time=2021-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107265, encodeId=e728110e265ef, content=什么是SCI？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107266, encodeId=8941110e26641, content=SCI文章有哪些类型？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192992, encodeId=4b572192992dc, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLqAtOxlBjLwnYC975r3m7HABJHvY7xNbmPLPWaEnvna2d66pia95rugk3sKOwGbr5VjMgWvjZn6iaQ/132, createdBy=74215322981, createdName=李卫秀, createdTime=Wed Mar 13 16:52:47 CST 2024, time=2024-03-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2192993, encodeId=89a121929930d, content=去, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLqAtOxlBjLwnYC975r3m7HABJHvY7xNbmPLPWaEnvna2d66pia95rugk3sKOwGbr5VjMgWvjZn6iaQ/132, createdBy=74215322981, createdName=李卫秀, createdTime=Wed Mar 13 16:53:08 CST 2024, time=2024-03-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2128630, encodeId=386121286300b, content=请问waiting reviewer selection是已经决定送审，在找审稿人吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d3c5204379, createdName=147470b1m83暂无昵称, createdTime=Thu Apr 27 10:25:11 CST 2023, time=2023-04-27, status=1, ipAttribution=湖南省)]
    2020-04-26 EthanYan

    审稿速度:3.0 | 投稿命中率:50.0
    经验分享：投了一篇儿科普外科罕见病，一审1个月15天，意见是大修，但审稿意见基本没有需要改的，2天修回，碰到疫情，二审1个月后直接接受！历时3个月15天！

    12

    展开12条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=589747, encodeId=1d0e589e47f8, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：投了一篇儿科普外科罕见病，一审1个月15天，意见是大修，但审稿意见基本没有需要改的，2天修回，碰到疫情，二审1个月后直接接受！历时3个月15天！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/07/ef2e683cb55b8fad1c6a2183144a4b1c.jpg, createdBy=6fee2203247, createdName=EthanYan, createdTime=Sun Apr 26 00:00:00 CST 2020, time=2020-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161543, encodeId=1f32216154340, content=偏重的研究方向：EUS<br>经验分享：目前Awaiting Reviewer Selection 状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb1a5029527, createdName=c040149, createdTime=Sun Oct 08 14:28:29 CST 2023, time=2023-10-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2149854, encodeId=e57721498548c, content=awaiting recommendation一般持续多久<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e4a12389361, createdName=婆婆丁, createdTime=Tue Jul 25 23:21:37 CST 2023, time=2023-07-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=589587, encodeId=244058958e35, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：其官网显示刊稿范围包括消化道（食管、胃、小肠、结直肠、肛门）、消化腺（肝、胆、胰、脾）以及肠内营养等相关学科的研究报道，旨在刊载胃肠病学领域的科研新成果、临床新技术、诊治新理念，文章类型包括评论、共识、综述、短篇报道、论著等。双月刊，JCR胃肠病学分区3区。 <br> 投稿系统简介便利，投稿一个月左右收到初审反馈，但感觉其网站作者指引不是特别明晰，因此后期修稿稍耗时。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c84c5323115, createdName=MedMN, createdTime=Fri Apr 24 10:12:00 CST 2020, time=2020-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920186, encodeId=d7389201869f, content=投了一篇临床研究。接受22天了，还没有给proof和要求交费，大家之前是多久收到的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJezw9rLVo7scpm4bIb34WhXb0deaXB8picW5eMAazAJHqyt2iaj4Zw6Uecu7jrAcuWiax5TTGr2reoA/132, createdBy=02e72292772, createdName=Godmin, createdTime=Wed Jan 27 07:15:07 CST 2021, time=2021-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107265, encodeId=e728110e265ef, content=什么是SCI？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107266, encodeId=8941110e26641, content=SCI文章有哪些类型？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192992, encodeId=4b572192992dc, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLqAtOxlBjLwnYC975r3m7HABJHvY7xNbmPLPWaEnvna2d66pia95rugk3sKOwGbr5VjMgWvjZn6iaQ/132, createdBy=74215322981, createdName=李卫秀, createdTime=Wed Mar 13 16:52:47 CST 2024, time=2024-03-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2192993, encodeId=89a121929930d, content=去, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLqAtOxlBjLwnYC975r3m7HABJHvY7xNbmPLPWaEnvna2d66pia95rugk3sKOwGbr5VjMgWvjZn6iaQ/132, createdBy=74215322981, createdName=李卫秀, createdTime=Wed Mar 13 16:53:08 CST 2024, time=2024-03-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2128630, encodeId=386121286300b, content=请问waiting reviewer selection是已经决定送审，在找审稿人吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d3c5204379, createdName=147470b1m83暂无昵称, createdTime=Thu Apr 27 10:25:11 CST 2023, time=2023-04-27, status=1, ipAttribution=湖南省)]
    2023-10-08 c040149 来自浙江省

    偏重的研究方向：EUS
    经验分享：目前Awaiting Reviewer Selection 状态

    9

    展开9条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=589747, encodeId=1d0e589e47f8, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：投了一篇儿科普外科罕见病，一审1个月15天，意见是大修，但审稿意见基本没有需要改的，2天修回，碰到疫情，二审1个月后直接接受！历时3个月15天！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/07/ef2e683cb55b8fad1c6a2183144a4b1c.jpg, createdBy=6fee2203247, createdName=EthanYan, createdTime=Sun Apr 26 00:00:00 CST 2020, time=2020-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161543, encodeId=1f32216154340, content=偏重的研究方向：EUS<br>经验分享：目前Awaiting Reviewer Selection 状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb1a5029527, createdName=c040149, createdTime=Sun Oct 08 14:28:29 CST 2023, time=2023-10-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2149854, encodeId=e57721498548c, content=awaiting recommendation一般持续多久<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e4a12389361, createdName=婆婆丁, createdTime=Tue Jul 25 23:21:37 CST 2023, time=2023-07-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=589587, encodeId=244058958e35, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：其官网显示刊稿范围包括消化道（食管、胃、小肠、结直肠、肛门）、消化腺（肝、胆、胰、脾）以及肠内营养等相关学科的研究报道，旨在刊载胃肠病学领域的科研新成果、临床新技术、诊治新理念，文章类型包括评论、共识、综述、短篇报道、论著等。双月刊，JCR胃肠病学分区3区。 <br> 投稿系统简介便利，投稿一个月左右收到初审反馈，但感觉其网站作者指引不是特别明晰，因此后期修稿稍耗时。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c84c5323115, createdName=MedMN, createdTime=Fri Apr 24 10:12:00 CST 2020, time=2020-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920186, encodeId=d7389201869f, content=投了一篇临床研究。接受22天了，还没有给proof和要求交费，大家之前是多久收到的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJezw9rLVo7scpm4bIb34WhXb0deaXB8picW5eMAazAJHqyt2iaj4Zw6Uecu7jrAcuWiax5TTGr2reoA/132, createdBy=02e72292772, createdName=Godmin, createdTime=Wed Jan 27 07:15:07 CST 2021, time=2021-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107265, encodeId=e728110e265ef, content=什么是SCI？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107266, encodeId=8941110e26641, content=SCI文章有哪些类型？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192992, encodeId=4b572192992dc, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLqAtOxlBjLwnYC975r3m7HABJHvY7xNbmPLPWaEnvna2d66pia95rugk3sKOwGbr5VjMgWvjZn6iaQ/132, createdBy=74215322981, createdName=李卫秀, createdTime=Wed Mar 13 16:52:47 CST 2024, time=2024-03-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2192993, encodeId=89a121929930d, content=去, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLqAtOxlBjLwnYC975r3m7HABJHvY7xNbmPLPWaEnvna2d66pia95rugk3sKOwGbr5VjMgWvjZn6iaQ/132, createdBy=74215322981, createdName=李卫秀, createdTime=Wed Mar 13 16:53:08 CST 2024, time=2024-03-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2128630, encodeId=386121286300b, content=请问waiting reviewer selection是已经决定送审，在找审稿人吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d3c5204379, createdName=147470b1m83暂无昵称, createdTime=Thu Apr 27 10:25:11 CST 2023, time=2023-04-27, status=1, ipAttribution=湖南省)]
    2023-07-25 婆婆丁 来自广东省

    awaiting recommendation一般持续多久

    2

    展开2条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=589747, encodeId=1d0e589e47f8, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：投了一篇儿科普外科罕见病，一审1个月15天，意见是大修，但审稿意见基本没有需要改的，2天修回，碰到疫情，二审1个月后直接接受！历时3个月15天！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/07/ef2e683cb55b8fad1c6a2183144a4b1c.jpg, createdBy=6fee2203247, createdName=EthanYan, createdTime=Sun Apr 26 00:00:00 CST 2020, time=2020-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161543, encodeId=1f32216154340, content=偏重的研究方向：EUS<br>经验分享：目前Awaiting Reviewer Selection 状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb1a5029527, createdName=c040149, createdTime=Sun Oct 08 14:28:29 CST 2023, time=2023-10-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2149854, encodeId=e57721498548c, content=awaiting recommendation一般持续多久<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e4a12389361, createdName=婆婆丁, createdTime=Tue Jul 25 23:21:37 CST 2023, time=2023-07-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=589587, encodeId=244058958e35, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：其官网显示刊稿范围包括消化道（食管、胃、小肠、结直肠、肛门）、消化腺（肝、胆、胰、脾）以及肠内营养等相关学科的研究报道，旨在刊载胃肠病学领域的科研新成果、临床新技术、诊治新理念，文章类型包括评论、共识、综述、短篇报道、论著等。双月刊，JCR胃肠病学分区3区。 <br> 投稿系统简介便利，投稿一个月左右收到初审反馈，但感觉其网站作者指引不是特别明晰，因此后期修稿稍耗时。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c84c5323115, createdName=MedMN, createdTime=Fri Apr 24 10:12:00 CST 2020, time=2020-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920186, encodeId=d7389201869f, content=投了一篇临床研究。接受22天了，还没有给proof和要求交费，大家之前是多久收到的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJezw9rLVo7scpm4bIb34WhXb0deaXB8picW5eMAazAJHqyt2iaj4Zw6Uecu7jrAcuWiax5TTGr2reoA/132, createdBy=02e72292772, createdName=Godmin, createdTime=Wed Jan 27 07:15:07 CST 2021, time=2021-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107265, encodeId=e728110e265ef, content=什么是SCI？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107266, encodeId=8941110e26641, content=SCI文章有哪些类型？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192992, encodeId=4b572192992dc, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLqAtOxlBjLwnYC975r3m7HABJHvY7xNbmPLPWaEnvna2d66pia95rugk3sKOwGbr5VjMgWvjZn6iaQ/132, createdBy=74215322981, createdName=李卫秀, createdTime=Wed Mar 13 16:52:47 CST 2024, time=2024-03-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2192993, encodeId=89a121929930d, content=去, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLqAtOxlBjLwnYC975r3m7HABJHvY7xNbmPLPWaEnvna2d66pia95rugk3sKOwGbr5VjMgWvjZn6iaQ/132, createdBy=74215322981, createdName=李卫秀, createdTime=Wed Mar 13 16:53:08 CST 2024, time=2024-03-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2128630, encodeId=386121286300b, content=请问waiting reviewer selection是已经决定送审，在找审稿人吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d3c5204379, createdName=147470b1m83暂无昵称, createdTime=Thu Apr 27 10:25:11 CST 2023, time=2023-04-27, status=1, ipAttribution=湖南省)]
    2020-04-24 MedMN

    审稿速度:1.0 | 投稿命中率:50.0
    经验分享：其官网显示刊稿范围包括消化道（食管、胃、小肠、结直肠、肛门）、消化腺（肝、胆、胰、脾）以及肠内营养等相关学科的研究报道，旨在刊载胃肠病学领域的科研新成果、临床新技术、诊治新理念，文章类型包括评论、共识、综述、短篇报道、论著等。双月刊，JCR胃肠病学分区3区。
    投稿系统简介便利，投稿一个月左右收到初审反馈，但感觉其网站作者指引不是特别明晰，因此后期修稿稍耗时。

    2

    展开2条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=589747, encodeId=1d0e589e47f8, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：投了一篇儿科普外科罕见病，一审1个月15天，意见是大修，但审稿意见基本没有需要改的，2天修回，碰到疫情，二审1个月后直接接受！历时3个月15天！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/07/ef2e683cb55b8fad1c6a2183144a4b1c.jpg, createdBy=6fee2203247, createdName=EthanYan, createdTime=Sun Apr 26 00:00:00 CST 2020, time=2020-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161543, encodeId=1f32216154340, content=偏重的研究方向：EUS<br>经验分享：目前Awaiting Reviewer Selection 状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb1a5029527, createdName=c040149, createdTime=Sun Oct 08 14:28:29 CST 2023, time=2023-10-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2149854, encodeId=e57721498548c, content=awaiting recommendation一般持续多久<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e4a12389361, createdName=婆婆丁, createdTime=Tue Jul 25 23:21:37 CST 2023, time=2023-07-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=589587, encodeId=244058958e35, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：其官网显示刊稿范围包括消化道（食管、胃、小肠、结直肠、肛门）、消化腺（肝、胆、胰、脾）以及肠内营养等相关学科的研究报道，旨在刊载胃肠病学领域的科研新成果、临床新技术、诊治新理念，文章类型包括评论、共识、综述、短篇报道、论著等。双月刊，JCR胃肠病学分区3区。 <br> 投稿系统简介便利，投稿一个月左右收到初审反馈，但感觉其网站作者指引不是特别明晰，因此后期修稿稍耗时。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c84c5323115, createdName=MedMN, createdTime=Fri Apr 24 10:12:00 CST 2020, time=2020-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920186, encodeId=d7389201869f, content=投了一篇临床研究。接受22天了，还没有给proof和要求交费，大家之前是多久收到的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJezw9rLVo7scpm4bIb34WhXb0deaXB8picW5eMAazAJHqyt2iaj4Zw6Uecu7jrAcuWiax5TTGr2reoA/132, createdBy=02e72292772, createdName=Godmin, createdTime=Wed Jan 27 07:15:07 CST 2021, time=2021-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107265, encodeId=e728110e265ef, content=什么是SCI？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107266, encodeId=8941110e26641, content=SCI文章有哪些类型？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192992, encodeId=4b572192992dc, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLqAtOxlBjLwnYC975r3m7HABJHvY7xNbmPLPWaEnvna2d66pia95rugk3sKOwGbr5VjMgWvjZn6iaQ/132, createdBy=74215322981, createdName=李卫秀, createdTime=Wed Mar 13 16:52:47 CST 2024, time=2024-03-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2192993, encodeId=89a121929930d, content=去, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLqAtOxlBjLwnYC975r3m7HABJHvY7xNbmPLPWaEnvna2d66pia95rugk3sKOwGbr5VjMgWvjZn6iaQ/132, createdBy=74215322981, createdName=李卫秀, createdTime=Wed Mar 13 16:53:08 CST 2024, time=2024-03-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2128630, encodeId=386121286300b, content=请问waiting reviewer selection是已经决定送审，在找审稿人吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d3c5204379, createdName=147470b1m83暂无昵称, createdTime=Thu Apr 27 10:25:11 CST 2023, time=2023-04-27, status=1, ipAttribution=湖南省)]
    2021-01-27 Godmin

    投了一篇临床研究。接受22天了，还没有给proof和要求交费，大家之前是多久收到的？

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=589747, encodeId=1d0e589e47f8, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：投了一篇儿科普外科罕见病，一审1个月15天，意见是大修，但审稿意见基本没有需要改的，2天修回，碰到疫情，二审1个月后直接接受！历时3个月15天！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/07/ef2e683cb55b8fad1c6a2183144a4b1c.jpg, createdBy=6fee2203247, createdName=EthanYan, createdTime=Sun Apr 26 00:00:00 CST 2020, time=2020-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161543, encodeId=1f32216154340, content=偏重的研究方向：EUS<br>经验分享：目前Awaiting Reviewer Selection 状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb1a5029527, createdName=c040149, createdTime=Sun Oct 08 14:28:29 CST 2023, time=2023-10-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2149854, encodeId=e57721498548c, content=awaiting recommendation一般持续多久<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e4a12389361, createdName=婆婆丁, createdTime=Tue Jul 25 23:21:37 CST 2023, time=2023-07-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=589587, encodeId=244058958e35, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：其官网显示刊稿范围包括消化道（食管、胃、小肠、结直肠、肛门）、消化腺（肝、胆、胰、脾）以及肠内营养等相关学科的研究报道，旨在刊载胃肠病学领域的科研新成果、临床新技术、诊治新理念，文章类型包括评论、共识、综述、短篇报道、论著等。双月刊，JCR胃肠病学分区3区。 <br> 投稿系统简介便利，投稿一个月左右收到初审反馈，但感觉其网站作者指引不是特别明晰，因此后期修稿稍耗时。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c84c5323115, createdName=MedMN, createdTime=Fri Apr 24 10:12:00 CST 2020, time=2020-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920186, encodeId=d7389201869f, content=投了一篇临床研究。接受22天了，还没有给proof和要求交费，大家之前是多久收到的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJezw9rLVo7scpm4bIb34WhXb0deaXB8picW5eMAazAJHqyt2iaj4Zw6Uecu7jrAcuWiax5TTGr2reoA/132, createdBy=02e72292772, createdName=Godmin, createdTime=Wed Jan 27 07:15:07 CST 2021, time=2021-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107265, encodeId=e728110e265ef, content=什么是SCI？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107266, encodeId=8941110e26641, content=SCI文章有哪些类型？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192992, encodeId=4b572192992dc, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLqAtOxlBjLwnYC975r3m7HABJHvY7xNbmPLPWaEnvna2d66pia95rugk3sKOwGbr5VjMgWvjZn6iaQ/132, createdBy=74215322981, createdName=李卫秀, createdTime=Wed Mar 13 16:52:47 CST 2024, time=2024-03-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2192993, encodeId=89a121929930d, content=去, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLqAtOxlBjLwnYC975r3m7HABJHvY7xNbmPLPWaEnvna2d66pia95rugk3sKOwGbr5VjMgWvjZn6iaQ/132, createdBy=74215322981, createdName=李卫秀, createdTime=Wed Mar 13 16:53:08 CST 2024, time=2024-03-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2128630, encodeId=386121286300b, content=请问waiting reviewer selection是已经决定送审，在找审稿人吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d3c5204379, createdName=147470b1m83暂无昵称, createdTime=Thu Apr 27 10:25:11 CST 2023, time=2023-04-27, status=1, ipAttribution=湖南省)]
    2021-12-28 msSSSSSD

    什么是SCI？

    1

    展开1条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=589747, encodeId=1d0e589e47f8, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：投了一篇儿科普外科罕见病，一审1个月15天，意见是大修，但审稿意见基本没有需要改的，2天修回，碰到疫情，二审1个月后直接接受！历时3个月15天！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/07/ef2e683cb55b8fad1c6a2183144a4b1c.jpg, createdBy=6fee2203247, createdName=EthanYan, createdTime=Sun Apr 26 00:00:00 CST 2020, time=2020-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161543, encodeId=1f32216154340, content=偏重的研究方向：EUS<br>经验分享：目前Awaiting Reviewer Selection 状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb1a5029527, createdName=c040149, createdTime=Sun Oct 08 14:28:29 CST 2023, time=2023-10-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2149854, encodeId=e57721498548c, content=awaiting recommendation一般持续多久<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e4a12389361, createdName=婆婆丁, createdTime=Tue Jul 25 23:21:37 CST 2023, time=2023-07-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=589587, encodeId=244058958e35, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：其官网显示刊稿范围包括消化道（食管、胃、小肠、结直肠、肛门）、消化腺（肝、胆、胰、脾）以及肠内营养等相关学科的研究报道，旨在刊载胃肠病学领域的科研新成果、临床新技术、诊治新理念，文章类型包括评论、共识、综述、短篇报道、论著等。双月刊，JCR胃肠病学分区3区。 <br> 投稿系统简介便利，投稿一个月左右收到初审反馈，但感觉其网站作者指引不是特别明晰，因此后期修稿稍耗时。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c84c5323115, createdName=MedMN, createdTime=Fri Apr 24 10:12:00 CST 2020, time=2020-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920186, encodeId=d7389201869f, content=投了一篇临床研究。接受22天了，还没有给proof和要求交费，大家之前是多久收到的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJezw9rLVo7scpm4bIb34WhXb0deaXB8picW5eMAazAJHqyt2iaj4Zw6Uecu7jrAcuWiax5TTGr2reoA/132, createdBy=02e72292772, createdName=Godmin, createdTime=Wed Jan 27 07:15:07 CST 2021, time=2021-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107265, encodeId=e728110e265ef, content=什么是SCI？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107266, encodeId=8941110e26641, content=SCI文章有哪些类型？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192992, encodeId=4b572192992dc, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLqAtOxlBjLwnYC975r3m7HABJHvY7xNbmPLPWaEnvna2d66pia95rugk3sKOwGbr5VjMgWvjZn6iaQ/132, createdBy=74215322981, createdName=李卫秀, createdTime=Wed Mar 13 16:52:47 CST 2024, time=2024-03-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2192993, encodeId=89a121929930d, content=去, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLqAtOxlBjLwnYC975r3m7HABJHvY7xNbmPLPWaEnvna2d66pia95rugk3sKOwGbr5VjMgWvjZn6iaQ/132, createdBy=74215322981, createdName=李卫秀, createdTime=Wed Mar 13 16:53:08 CST 2024, time=2024-03-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2128630, encodeId=386121286300b, content=请问waiting reviewer selection是已经决定送审，在找审稿人吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d3c5204379, createdName=147470b1m83暂无昵称, createdTime=Thu Apr 27 10:25:11 CST 2023, time=2023-04-27, status=1, ipAttribution=湖南省)]
    2021-12-29 msSSSSSD

    SCI文章有哪些类型？

    1

    展开1条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=589747, encodeId=1d0e589e47f8, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：投了一篇儿科普外科罕见病，一审1个月15天，意见是大修，但审稿意见基本没有需要改的，2天修回，碰到疫情，二审1个月后直接接受！历时3个月15天！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/07/ef2e683cb55b8fad1c6a2183144a4b1c.jpg, createdBy=6fee2203247, createdName=EthanYan, createdTime=Sun Apr 26 00:00:00 CST 2020, time=2020-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161543, encodeId=1f32216154340, content=偏重的研究方向：EUS<br>经验分享：目前Awaiting Reviewer Selection 状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb1a5029527, createdName=c040149, createdTime=Sun Oct 08 14:28:29 CST 2023, time=2023-10-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2149854, encodeId=e57721498548c, content=awaiting recommendation一般持续多久<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e4a12389361, createdName=婆婆丁, createdTime=Tue Jul 25 23:21:37 CST 2023, time=2023-07-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=589587, encodeId=244058958e35, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：其官网显示刊稿范围包括消化道（食管、胃、小肠、结直肠、肛门）、消化腺（肝、胆、胰、脾）以及肠内营养等相关学科的研究报道，旨在刊载胃肠病学领域的科研新成果、临床新技术、诊治新理念，文章类型包括评论、共识、综述、短篇报道、论著等。双月刊，JCR胃肠病学分区3区。 <br> 投稿系统简介便利，投稿一个月左右收到初审反馈，但感觉其网站作者指引不是特别明晰，因此后期修稿稍耗时。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c84c5323115, createdName=MedMN, createdTime=Fri Apr 24 10:12:00 CST 2020, time=2020-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920186, encodeId=d7389201869f, content=投了一篇临床研究。接受22天了，还没有给proof和要求交费，大家之前是多久收到的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJezw9rLVo7scpm4bIb34WhXb0deaXB8picW5eMAazAJHqyt2iaj4Zw6Uecu7jrAcuWiax5TTGr2reoA/132, createdBy=02e72292772, createdName=Godmin, createdTime=Wed Jan 27 07:15:07 CST 2021, time=2021-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107265, encodeId=e728110e265ef, content=什么是SCI？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107266, encodeId=8941110e26641, content=SCI文章有哪些类型？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192992, encodeId=4b572192992dc, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLqAtOxlBjLwnYC975r3m7HABJHvY7xNbmPLPWaEnvna2d66pia95rugk3sKOwGbr5VjMgWvjZn6iaQ/132, createdBy=74215322981, createdName=李卫秀, createdTime=Wed Mar 13 16:52:47 CST 2024, time=2024-03-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2192993, encodeId=89a121929930d, content=去, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLqAtOxlBjLwnYC975r3m7HABJHvY7xNbmPLPWaEnvna2d66pia95rugk3sKOwGbr5VjMgWvjZn6iaQ/132, createdBy=74215322981, createdName=李卫秀, createdTime=Wed Mar 13 16:53:08 CST 2024, time=2024-03-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2128630, encodeId=386121286300b, content=请问waiting reviewer selection是已经决定送审，在找审稿人吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d3c5204379, createdName=147470b1m83暂无昵称, createdTime=Thu Apr 27 10:25:11 CST 2023, time=2023-04-27, status=1, ipAttribution=湖南省)]
    2024-03-13 李卫秀 来自四川省

    无

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=589747, encodeId=1d0e589e47f8, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：投了一篇儿科普外科罕见病，一审1个月15天，意见是大修，但审稿意见基本没有需要改的，2天修回，碰到疫情，二审1个月后直接接受！历时3个月15天！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/07/ef2e683cb55b8fad1c6a2183144a4b1c.jpg, createdBy=6fee2203247, createdName=EthanYan, createdTime=Sun Apr 26 00:00:00 CST 2020, time=2020-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161543, encodeId=1f32216154340, content=偏重的研究方向：EUS<br>经验分享：目前Awaiting Reviewer Selection 状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb1a5029527, createdName=c040149, createdTime=Sun Oct 08 14:28:29 CST 2023, time=2023-10-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2149854, encodeId=e57721498548c, content=awaiting recommendation一般持续多久<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e4a12389361, createdName=婆婆丁, createdTime=Tue Jul 25 23:21:37 CST 2023, time=2023-07-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=589587, encodeId=244058958e35, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：其官网显示刊稿范围包括消化道（食管、胃、小肠、结直肠、肛门）、消化腺（肝、胆、胰、脾）以及肠内营养等相关学科的研究报道，旨在刊载胃肠病学领域的科研新成果、临床新技术、诊治新理念，文章类型包括评论、共识、综述、短篇报道、论著等。双月刊，JCR胃肠病学分区3区。 <br> 投稿系统简介便利，投稿一个月左右收到初审反馈，但感觉其网站作者指引不是特别明晰，因此后期修稿稍耗时。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c84c5323115, createdName=MedMN, createdTime=Fri Apr 24 10:12:00 CST 2020, time=2020-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920186, encodeId=d7389201869f, content=投了一篇临床研究。接受22天了，还没有给proof和要求交费，大家之前是多久收到的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJezw9rLVo7scpm4bIb34WhXb0deaXB8picW5eMAazAJHqyt2iaj4Zw6Uecu7jrAcuWiax5TTGr2reoA/132, createdBy=02e72292772, createdName=Godmin, createdTime=Wed Jan 27 07:15:07 CST 2021, time=2021-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107265, encodeId=e728110e265ef, content=什么是SCI？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107266, encodeId=8941110e26641, content=SCI文章有哪些类型？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192992, encodeId=4b572192992dc, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLqAtOxlBjLwnYC975r3m7HABJHvY7xNbmPLPWaEnvna2d66pia95rugk3sKOwGbr5VjMgWvjZn6iaQ/132, createdBy=74215322981, createdName=李卫秀, createdTime=Wed Mar 13 16:52:47 CST 2024, time=2024-03-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2192993, encodeId=89a121929930d, content=去, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLqAtOxlBjLwnYC975r3m7HABJHvY7xNbmPLPWaEnvna2d66pia95rugk3sKOwGbr5VjMgWvjZn6iaQ/132, createdBy=74215322981, createdName=李卫秀, createdTime=Wed Mar 13 16:53:08 CST 2024, time=2024-03-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2128630, encodeId=386121286300b, content=请问waiting reviewer selection是已经决定送审，在找审稿人吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d3c5204379, createdName=147470b1m83暂无昵称, createdTime=Thu Apr 27 10:25:11 CST 2023, time=2023-04-27, status=1, ipAttribution=湖南省)]
    2024-03-13 李卫秀 来自四川省

    去

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=589747, encodeId=1d0e589e47f8, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：投了一篇儿科普外科罕见病，一审1个月15天，意见是大修，但审稿意见基本没有需要改的，2天修回，碰到疫情，二审1个月后直接接受！历时3个月15天！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/07/ef2e683cb55b8fad1c6a2183144a4b1c.jpg, createdBy=6fee2203247, createdName=EthanYan, createdTime=Sun Apr 26 00:00:00 CST 2020, time=2020-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161543, encodeId=1f32216154340, content=偏重的研究方向：EUS<br>经验分享：目前Awaiting Reviewer Selection 状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb1a5029527, createdName=c040149, createdTime=Sun Oct 08 14:28:29 CST 2023, time=2023-10-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2149854, encodeId=e57721498548c, content=awaiting recommendation一般持续多久<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e4a12389361, createdName=婆婆丁, createdTime=Tue Jul 25 23:21:37 CST 2023, time=2023-07-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=589587, encodeId=244058958e35, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：其官网显示刊稿范围包括消化道（食管、胃、小肠、结直肠、肛门）、消化腺（肝、胆、胰、脾）以及肠内营养等相关学科的研究报道，旨在刊载胃肠病学领域的科研新成果、临床新技术、诊治新理念，文章类型包括评论、共识、综述、短篇报道、论著等。双月刊，JCR胃肠病学分区3区。 <br> 投稿系统简介便利，投稿一个月左右收到初审反馈，但感觉其网站作者指引不是特别明晰，因此后期修稿稍耗时。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c84c5323115, createdName=MedMN, createdTime=Fri Apr 24 10:12:00 CST 2020, time=2020-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920186, encodeId=d7389201869f, content=投了一篇临床研究。接受22天了，还没有给proof和要求交费，大家之前是多久收到的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJezw9rLVo7scpm4bIb34WhXb0deaXB8picW5eMAazAJHqyt2iaj4Zw6Uecu7jrAcuWiax5TTGr2reoA/132, createdBy=02e72292772, createdName=Godmin, createdTime=Wed Jan 27 07:15:07 CST 2021, time=2021-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107265, encodeId=e728110e265ef, content=什么是SCI？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107266, encodeId=8941110e26641, content=SCI文章有哪些类型？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192992, encodeId=4b572192992dc, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLqAtOxlBjLwnYC975r3m7HABJHvY7xNbmPLPWaEnvna2d66pia95rugk3sKOwGbr5VjMgWvjZn6iaQ/132, createdBy=74215322981, createdName=李卫秀, createdTime=Wed Mar 13 16:52:47 CST 2024, time=2024-03-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2192993, encodeId=89a121929930d, content=去, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLqAtOxlBjLwnYC975r3m7HABJHvY7xNbmPLPWaEnvna2d66pia95rugk3sKOwGbr5VjMgWvjZn6iaQ/132, createdBy=74215322981, createdName=李卫秀, createdTime=Wed Mar 13 16:53:08 CST 2024, time=2024-03-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2128630, encodeId=386121286300b, content=请问waiting reviewer selection是已经决定送审，在找审稿人吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d3c5204379, createdName=147470b1m83暂无昵称, createdTime=Thu Apr 27 10:25:11 CST 2023, time=2023-04-27, status=1, ipAttribution=湖南省)]
    2023-04-27 147470b1m83暂无昵称 来自湖南省

    请问waiting reviewer selection是已经决定送审，在找审稿人吗？

    0

共40条页码: 1/4页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分